Search Results
Feb 24, 2026, 09:00 ET The Gross Law Firm Reminds uniQure Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 13, 2026 - QURE
https://securitiesclasslaw.com/securities/uniqure-loss-submission-form/?id=183769&from=4CLASS PERIOD: September 24, 2025 to October 31, 2025ALLEGATIONS: The complaint
More news about: The Gross Law Firm
Feb 24, 2026, 09:00 ET Picard Medical, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before April 3, 2026 to Discuss Your Rights - PMI
https://securitiesclasslaw.com/securities/picard-medical-inc-loss-submission-form/?id=183760&from=4CLASS PERIOD: September 2, 2025 to October 31, 2025ALLEGATIONS: The complaint
More news about: The Gross Law Firm
Feb 24, 2026, 09:00 ET The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 2, 2026 in agilon health, inc. Lawsuit - AGL
https://securitiesclasslaw.com/securities/agilon-health-inc-loss-submission-form/?id=183749&from=4CLASS PERIOD: February 26, 2025 to August 4, 2025ALLEGATIONS: The complaint
More news about: The Gross Law Firm
Feb 24, 2026, 09:00 ET Shareholders that lost money on Ostin Technology Group Co., Ltd.(OST) should contact The Gross Law Firm about pending Class Action - OST
https://securitiesclasslaw.com/securities/ostin-technology-group-co-ltd-loss-submission-form/?id=183771&from=4CLASS PERIOD: May 11, 2025 to June 26, 2025ALLEGATIONS: The complaint
More news about: The Gross Law Firm
Feb 24, 2026, 09:00 ET BRBR LAWSUIT ALERT: The Gross Law Firm Notifies BellRing Brands, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
https://securitiesclasslaw.com/securities/bellring-brands-inc-loss-submission-form/?id=183756&from=4CLASS PERIOD: November 19, 2024 to August 4, 2025ALLEGATIONS: According
More news about: The Gross Law Firm
Feb 24, 2026, 09:00 ET Investors who lost money on Plug Power Inc.(PLUG) should contact The Gross Law Firm about pending Class Action - PLUG
https://securitiesclasslaw.com/securities/plug-power-loss-submission-form/?id=183761&from=4CLASS PERIOD: January 17, 2025 to November 13, 2025ALLEGATIONS: The complaint
More news about: The Gross Law Firm
Feb 24, 2026, 09:00 ET Investors in Inovio Pharmaceuticals, Inc. Should Contact The Gross Law Firm Before April 7, 2026 to Discuss Your Rights - INO
https://securitiesclasslaw.com/securities/inovio-pharmaceuticals-inc-loss-submission-form-2/?id=183766&from=4CLASS PERIOD: October 10, 2023 to December 26, 2025ALLEGATIONS: The
More news about: The Gross Law Firm
Feb 24, 2026, 09:00 ET Lost Money on Kyndryl Holdings, Inc.(KD)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
https://securitiesclasslaw.com/securities/kyndryl-holdings-loss-submission-form/?id=183768&from=4CLASS PERIOD: August 7, 2024 to February 9, 2026ALLEGATIONS: The complaint
More news about: The Gross Law Firm
Feb 24, 2026, 09:00 ET The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 13, 2026 in Bath & Body Works, Inc. Lawsuit - BBWI
https://securitiesclasslaw.com/securities/bath-body-works-inc-loss-submission-form/?id=183754&from=4CLASS PERIOD: June 4, 2024 to November 9, 2025ALLEGATIONS: The complaint
More news about: The Gross Law Firm
Feb 24, 2026, 09:00 ET The Gross Law Firm Notifies Paysafe Limited Investors of a Class Action Lawsuit and Upcoming Deadline - PSFE
https://securitiesclasslaw.com/securities/paysafe-limited-loss-submission-form/?id=183767&from=4CLASS PERIOD: March 4, 2025 to November 12, 2025ALLEGATIONS: The complaint
More news about: The Gross Law Firm
Feb 24, 2026, 09:00 ET The Gross Law Firm Notifies Shareholders of Fermi Inc.(FRMI) of a Class Action Lawsuit and an Upcoming Deadline
https://securitiesclasslaw.com/securities/fermi-inc-loss-submission-form/?id=183750&from=4CLASS PERIOD: This lawsuit is on behalf of persons and entities that purchased or otherwise
More news about: The Gross Law Firm
Feb 24, 2026, 09:00 ET The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 6, 2026 in Mereo BioPharma Group plc Lawsuit - MREO
https://securitiesclasslaw.com/securities/mereo-biopharma-group-plc-loss-submission-form-5/?id=183763&from=4CLASS PERIOD: June 5, 2023 to December 26, 2025ALLEGATIONS: According
More news about: The Gross Law Firm
Feb 24, 2026, 09:00 ET Class Action Filed Against Vistagen Therapeutics, Inc. (VTGN) - March 16, 2026 Deadline to Join - Contact The Gross Law Firm
https://securitiesclasslaw.com/securities/vistagen-therapeutics-inc-loss-submission-form/?id=183755&from=4CLASS PERIOD: April 1, 2024 to December 16, 2025ALLEGATIONS: According
More news about: The Gross Law Firm
Feb 24, 2026, 09:00 ET NuScale Power Corporation Class Action: The Gross Law Firm Reminds NuScale Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 20, 2026 - SMR
https://securitiesclasslaw.com/securities/nuscale-power-corporation-loss-submission-form/?id=183773&from=4CLASS PERIOD: May 13, 2025 to November 6, 2025ALLEGATIONS: The complaint
More news about: The Gross Law Firm
Feb 24, 2026, 09:00 ET Ardent Health, Inc. Class Action: The Gross Law Firm Reminds Ardent Health, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 9, 2026 - ARDT
https://securitiesclasslaw.com/securities/ardent-health-inc-loss-submission-form/?id=183752&from=4CLASS PERIOD: July 18, 2024 to November 12, 2025ALLEGATIONS: According
More news about: The Gross Law Firm
Feb 24, 2026, 09:00 ET The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Ultragenyx Pharmaceutical Inc.(RARE) Shareholders
https://securitiesclasslaw.com/securities/ultragenyx-pharmaceutical-inc-loss-submission-form-2/?id=183764&from=4CLASS PERIOD: August 3, 2023 to December 26, 2025ALLEGATIONS: According
More news about: The Gross Law Firm
Feb 24, 2026, 09:00 ET The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2026 in REGENXBIO Lawsuit - RGNX
https://securitiesclasslaw.com/securities/regenxbio-inc-loss-submission-form/?id=183770&from=4CLASS PERIOD: February 9, 2022 to January 27, 2026ALLEGATIONS: According
More news about: The Gross Law Firm
Feb 24, 2026, 09:00 ET Contact The Gross Law Firm by March 9, 2026 Deadline to Join Class Action Against Varonis Systems, Inc.(VRNS)
https://securitiesclasslaw.com/securities/varonis-systems-inc-loss-submission-form/?id=183751&from=4CLASS PERIOD: February 4, 2025 to October 28, 2025ALLEGATIONS: According
More news about: The Gross Law Firm
Feb 24, 2026, 09:00 ET PayPal Holdings, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - PYPL
https://securitiesclasslaw.com/securities/paypal-holdings-inc-loss-submission-form/?id=183774&from=4CLASS PERIOD: February 25, 2025 to February 2, 2026ALLEGATIONS: According
More news about: The Gross Law Firm
Feb 24, 2026, 09:00 ET AtomVie Global Radiopharma Supplies First Patient Dose in Radiopharm Theranostics' Phase 1/2a Clinical Study of 177Lu-BetaBart (RV-01)
radiopharmtheranostics.com.For more information, please contact:Riccardo Canevari, CEO & Managing DirectorPhone number: +1 862 309 0293e-mail id: [email protected] AtomVie(AtomVie)AtomVie
More news about: AtomVie Global Radiopharma Inc.
Feb 24, 2026, 09:00 ET AtomVie Global Radiopharma Supplies First Patient Dose in Radiopharm Theranostics' Phase 1/2a Clinical Study of 177Lu-BetaBart (RV-01)
radiopharmtheranostics.com.For more information, please contact:Riccardo Canevari, CEO & Managing DirectorPhone number: +1 862 309 0293e-mail id: [email protected] AtomVie(AtomVie)AtomVie
More news about: AtomVie Global Radiopharma Inc.
Feb 24, 2026, 09:00 ET AtomVie Global Radiopharma liefert erste Patientendosis in Phase 1/2a der klinischen Studie von Radiopharm Theranostics mit 177Lu-BetaBart (RV-01)
weitere Informationen wenden Sie sich bitte an:Riccardo Canevari, CEO & GeschäftsführerTelefonnummer: +1 862 309 0293e-mail id: [email protected]Über AtomVie(AtomVie)AtomVie
More news about: AtomVie Global Radiopharma Inc.
Feb 24, 2026, 09:00 ET AtomVie Global Radiopharma suministra la primera dosis en el estudio clínico de Radiopharm Theranostics
radiopharmtheranostics.com.Para obtener más información, contacte con:Riccardo Canevari, consejero delegado y director gerente Tel: +1 862 309 0293ID de correo electrónico: [email protected]
More news about: AtomVie Global Radiopharma Inc.
Feb 24, 2026, 09:00 ET AtomVie Global Radiopharma fournit la première dose à un patient dans le cadre de l'étude clinique de phase 1/2a de Radiopharm Theranostics sur le 177Lu-BetaBart (RV-01)
d'informations, veuillez contacter :Riccardo Canevari, PDG et directeur généralNuméro de téléphone : +1 862 309 0293e-mail id : [email protected]À propos d'AtomVie(AtomVie)AtomVie
More news about: AtomVie Global Radiopharma Inc.
Feb 24, 2026, 08:52 ET TempDev Launches Chronic Care Management 2.0 Template Suite to Enhance Patient-Centered Care and Improve Reimbursement Outcomes
tests, and checkupsMonitor care plan statusAccess patient charts instantly for follow-upsSort and filter by patient, status, ID number, and other criteriaThis enhanced visibility ensures no critical element of a patient's care plan is overlooked.Enhanced
More news about: TempDev